Celldex Therapeutics, Inc.

Direct answer

Celldex Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CLDX.

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the...

Can you invest in Celldex Therapeutics, Inc.?

Yes. Celldex Therapeutics, Inc. trades publicly on NASDAQ as CLDX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Celldex Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.